Companies: BiotechEast Co., Ltd. (Technology Partner)

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs; Forums
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Companies
Company details

BiotechEast Co., Ltd. (Technology Partner)

BiotechEast is a one-stop, full-service marketing consultancy for those looking to take advantage of the dynamic opportunities in Taiwan's burgeoning life science industry.

Profile

BiotechEast is a one-stop, full-service marketing consultancy for those looking to take advantage of the dynamic opportunities in Taiwan's burgeoning life science industry (ranked No. 1 in Asian biotechnology by SG Cowen Securities-2001).

Our multinational, bilingual team offers a range of relationship- building services and connections with major Taiwanese players within the private sector and with government-level biotech decision makers.

We offer:

• Identifying and screening manufacturers for products and development projects utilizing BiotechEast's vast information and contact network

• Information collecting; staffing data, main products, technology overview, financials (when available)

• Partner selection/suggestion based on BiotechEast's expert experience and in-depth knowledge of local industry

• Product sample obtaining and sending, filming of product in demo use

• Meeting representation: BiotechEast provides a Mandarin- capable presence and industry insider to sit at the table with existing and prospective clients

• Factory check: investigation of accreditation, validation of manufacturer's claims

• Factory follow-on visits: product development maintenance and management (once monthly for ongoing development projects)

• Partner management: BiotechEast specializes in overcoming common off-shoring difficulties such as language, cultural and trust-building in bridging and building long-term business relationships between the local manufacturer and overseas partner

• Trip liaison services, scheduling, seminar preparation, events promotions

• Technology transfer and licensing opportunities

Partnering strategy/interests

BiotechEast gives Taiwan companies and institutes the ability to internationlize; helping them more effectively connect to the global biotechnology industry through a wide range of business facilitation services. Currently we are focused on promoting our life science technology promotion platform whereby local companies or institutes use BiotechEast's wide overseas network of channels and contacts to promote technologies that they wish to outlicense or sell.

Out-licensing

Academia Sinica: A new organometallic complex as an efficient DNA molecule binder

The invention relates to a potential anti-cancer drug, an efficient DNA binder and photo-induced DNA-cleaving agent composition, in particular, the use of a new organoplatinum complex as an efficient DNA binder and photo-induced DNA-cleaving agent. More

Academia Sinica: Characterization and identification of pulmonary stem cells as a target for viral infection

The technology involves the characterization and identification of pulmonary stem cells as a target for viral infection. Application includes respiratory infection cell model, respiratory infection drug screening, lung tissue regenerative therapy More

Animal Technology Institute Taiwan (ATIT): A platform for the expression and production of multiple recombinant proteins in the milk of transgenic non-human mammals

Technology regarding new methods to efficiently and cost-effectively produce recombinant proteins from the milk of genetically-modified farm animals, applying methodologies of genetic engineering and transgenesis to pharmaceutical manufacturing. More

BrainGenesis Biotechnology: BNG-1: Treatment for ischemia stroke

A novel mixture of traditional Chinese medicines with anti-platelet aggregation and anti-thrombotic activity for both prevention and treatment of cerebral stroke. More

Golden Biotechnology: Antroquinonol®, a new chemical entity with application in cancer therapy and auto-immune disease therapy

Antroquinonol® is a non-toxic, highly effective cancer treatment agent, developed using natural organic chemistry. More

Life Spring Biotech: iGen™—a biodegradable collagen implant for glaucoma, pterygium and selected ophthalmic laser and ophthalmic surgery treatment

iGen™ is a collagen implant, and is a biodegradable scaffold which can induce a regenerative non-scarring wound healing process without the use of medicine. The ophthalmology applications for iGenÂ include glaucoma, pterygium, ocular tissue, and More

Life Spring Biotech: SmarBUCKL ---A scleral buckling band used for retinal detachment

SmarBUCKL is produced with biocompatible and slow-resorbing biomaterials which will not induce immunoreactions and can be resorbed after implantation. The SmarBUCKL doesn't need to be exteriorized by a second operation after patient recovers. More

Medigreen: 1217B- Asthma treatment

1217B is a botanically derived potential drug candidate that inhibits the synthesis of several key pro-inflammatory mediators involved in the pathophysiology of allergic asthma and has been found to improve lung functionality in a mouse model. More

Medigreen: CA-88-Cancer chemotherapy and radiotherapy auxiliary treatment

CA-88 is a botanically derived auxiliary treatment that has been shown to exhibit healthful benefits for patients undergoing cancer chemotherapy and radiotherapy. More

Medigreen: MIC-31- Gastric ulcer treatment

MIC-31 is a botanically derived potential drug candidate for gastric ulcer prevention and therapy. More

Microbio: MS-20: A fermented soy extract for inhibiting cancer growth, reducing infection and promoting general health, with the technology also covering the method used to do so

A fermented soymilk extract, MS-20, is in Phase II (US FDA and Taiwan DOH) and Phase III (Taiwan DOH) clinical trials for the treatment of cachexia in liver cancer patients and for reducing neutropenic fever in cancer patients undergoing chemotherapy More

Microbio: WH-1: A botanical drug for the treatment of diabetic foot ulcers and the management of similar chronic wound healing conditions

A botanical drug, WH-1, has been approved for US FDA Phase II clinical trials for the treatment of diabetic foot ulcers and also potentially indicated for similar chronic wound healing management conditions. More

National Taiwan University: Composition of agent for the prevention and treatment of Alzheimer's disease, and the method of said agent

Composition of agent for the prevention and treatment of Alzheimer's disease, and the method of said agent, comprising of monacolins, anti-inflammation agents and anti-oxidant compounds extracted from red mold rice (RMR). More

National Taiwan University: Method for producing eggs with low cholesterol levels

New method for producing low cholesterol eggs through the addition of fermented red mold rice (RMR) to hen's feed. More

NatureWise Biotech & Medicals Corporation: New compounds for growth media, showing stimulation effects on neural stem cell growth and activity

A number of specific PPLs, a group of prenylflavanone compounds, some novel, were isolated, identified and tested at as low as 0.04 μg/mL to be able to increase survival of neural stem cells, to promote neuronal growth with lengthening of neurite More

NatureWise Biotech & Medicals Corporation: New compounds showing cell cycle gene regulation, with implications for new cancer therapies

Two new compounds having HDAC (histone deacetylase) inhibition capability have shown the effect of inducing re-differentiation of human brain and breast cancer cells both in vitro and in vivo. More

PharmaEssentia Corp.: Novel site-specific PEGylated interferon-alpha (P1101) for treatment of Hepatitis B and C

Third generation long-acting, site-specific PEGylated interferon-alpha, having one predominate positional isomer, offering a longer half-life and so requiring a less frequent dosage regime. The new design also gives improved production yields. More

PharmiGene Inc.: Technology associated with the PG 1502 DNA Detection Kit and the PG1502 FastGel Kit

Technology associated with PharmiGene's PG 1502 DNA Detection Kit and the PG1502 FastGel Kit, kits to determine the risk of Carbamazepine-induced SJS/TEN adverse drug reaction (ADR). More

PharmiGene Inc.: Technology associated with the Warfarin Dose Prediction Kit

Technology associated with PharmiGene's Warfarin Dose Prediction Kit, a kit to determine the appropriate Warfarin dosage administration based on the presence of the VKORC1-1639 and CYP2C9 genes. More

PharmiGene Inc.:Technology associated with the PG 5801 DNA Detection Kit and the PG 5801 FastGel Kit

Technology associated with PharmiGene's PG 5801 DNA Detection Kit and the PG 5801 FastGel Kit, kits to determine the risk of Allopurinol-induced severe cutaneous adverse reaction (SCAR). More

Phytohealth Corporation: PH3 (PHN031, PHN033) - For osteoporosis and diabetic vascular complications

Patented technology regarding new and safe mechanism with the active substance PH3 for the indications of osteoporosis and diabetic vascular complications. More

Phytohealth Corporation: PHN032 - Adjuvant for oral/nasal vaccines against influenza and bird influenza

Patented technology regarding a superior adjuvant with the active substance polysaccharide for oral/nasal vaccines against influenza and bird influenza, targeted to the aging population. More

PITDC: Anti-depression pharmaceutical composition containing Polygala extract

Anti-depression More

PITDC: Anti-ulcer pharmaceutical composition and the preparation thereof

Anti-peptic ulcer, anti-gastritis More

PITDC: Formula and preparation method of an improved ointment for treating burns and scalds

Treating burns and scalds More

PITDC: Method of preparing an extract potent in anti-inflammation, anti-platelet aggregation and anti-fungal activity from Zingiber officinale, and pharmaceutical compositions containing said extract

Anti-inflammation, anti-platelet aggregation, anti-fungal More

PITDC: Novel compound for treatment of treatment of bacterial infections and/or renal cancer disease

Active ingredient for the treatment of bacterial infections and/or renal cancer diseases More

SunTen Phytotech: STD052/07: STD052/07- Fractionated herbal extract demonstrating cholesterol/triglyceride lowering; and a drug candidate for the treatment of GI disorders developed from a single active compound

A fractionated herbal extract (STD052) demonstrating cholesterol/triglyceride lowering properties, purified down to a single active compound (STD07), a potential drug candidate for the treatment of GI disorders. More

SunTen Phytotech: STD06: Combination of active ingredients for treatment of various skin diseases

An active ingredient purified from herbal material for the treatment of skin disorders and for wound-healing. More

Press Releases

PhytoHealth begins Phase II clinical trial on new botanically-derived osteoporosis drug after receiving FDA approval

(30th May 2008) PhytoHealth begins Phase II clinical trial on new botanically-derived osteoporosis drug after receiving FDA approval More

NatureWise announces updates on cancer drug candidate, neurotrophic factors for neurodegenerative disorders

(6th Jun 2008) Drug discovery and development firm NatureWise Biotech & Medicals Corp. announces two major updates to its pipeline: NBM-HD-1 for brain cancer and SMA therapy drug candidate, and neurotrophic agents from PPLs for neurodegenerative disease therapy More

Life Spring BioTech seeking new distribution partners worldwide for its iGen collagen matrix implant for ophthalmic surgery

(16th Apr 2008) Life Spring BioTech Co., Ltd., a Taiwan-based biotech company focusing on the R&D and manufacture of innovative collagen products for medical/cosmetic applications, is seeking new distribution partners for its iGen collagen matrix implant product. More

PharmaEssentia announces milestone in development of new third-generation interferon hepatitis B and C drug candidate

(18th Jun 2008) Drug development company PharmaEssentia Corp. announced that new PK/PD data on P1101, its third-generation PEG-INF-alpha drug candidate for hepatitis B and C, is particularly long-lasting compared to the two other pegylated drugs on the market. More

PharmiGene receives regulatory approval for test assessing risk of adverse drug reaction to Carbamazepine

(22nd Aug 2008) Pharmacogenomics-based diagnostics test identifying patients with greater risk of Carbamazepine-induced adverse drug reaction is world's first, and a milestone towards personalized medicine. More

Botanical medicine providing rich pickings for Taiwanese drug discovery companies

(9th Sep 2008) Increasing numbers of companies within Taiwan's burgeoning life science industry space are parlaying Traditional Chinese Medicine (TCM) know-how into all the development of new drug candidates covering a wide range of unmet medical needs. More

Excellence and innovation in life sciences recognized at awards event: PharmiGene wins top prize, Life Spring Biotech comes in second, Mycenax Biotech and PhytoHealth share third

(6th Nov 2008) Taiwan's blossoming life sciences sector came under the spotlight today as some of the most promising companies were recognized at the More

PharmiGene obtains European patent for genetic discovery predicting warfarin sensitivity

(24th Mar 2009) Pharmacogenetics company PharmiGene, Inc. has received European patent for the identification of genetic variations in the human VKORC1-1639 gene, related to sensitivity to the anti-coagulant drug warfarin. More

GenMont probiotics products receive China market entry approval

(16th Apr 2009) Two probiotic strains “GM-080” and “GMNL-33,” developed and marketed by GenMont Biotech Inc., (TWOTC: 3164) have been approved by regulatory agencies in China, and can now be used as additive ingredients to food products in that market. More

Medigreen announces MAF, a new botanical-based anti-allergy formulation

(28th Apr 2009) At a forum focusing on allergy causes and treatment strategies held in Taipei, botanically-derived health products company Medigreen Biotechnology unveiled its new anti-allergy formulation More

BioBusiness Asia 2009 opens in Taipei

(21st Jul 2009) The eighth BioBusiness Asia conference, a two-day gathering of life science business professionals from around Asia held annually in Taipei, Taiwan, opened its doors today. More

PharmaEssentia's long-acting HC/BV drug candidate P1101 (PEG-P-IFN-alpha-2b) receives FDA IND approval

(5th Aug 2009) PharmaEssentia's third-generation interferon drug candidate P1101 (PEG-P-IFN-alpha-2b) for the treatment of hepatitis B and C, has received US FDA IND approval, with Phase I clinical trials in both Canada and Taiwan set to begin in the third quarter of 20 More

(22nd Oct 2009) Protein drug development company Mycenax Biotech Inc. (GreTai, Taiwan: 4726) announced today that its rheumatoid arthritis and psoriasis drug TuNEX®, a biosimilar version of etanercept, has successfully completed a Phase I trial in South Korea and Phase I More

More press releases

Contact details

Mr. David Silver
President

Contact directly

Full contact list

Head office

BiotechEast Co., Ltd. (Technology Partner)
14F, Shin Kong Manhattan Building
8 Xinyi Rd., Sec. 5, Xinyi District,
Taipei
11049
Taiwan

Visit website

Contact head office

Company figures

Formed: 2001

Related categories

Industry sector: Academic/Research / Pharmaceutical; Biotechnology / Assay systems; Biotechnology / Human therapeutics; Biotechnology / Stem cells; Drug delivery / Oral solid; Drug delivery / Nasal; Drug delivery / Nasal topical; Drug delivery / Oral solid / Tablet; Drug delivery / Oral solid / Capsule; Drug delivery / Topical / Oral; Drug delivery / Oral solid / Tablet / Freeze-dried; Drug delivery / Oral solid / Tablet / Sublingual; Drug delivery / Topical / Dermatological / Spray; Drug discovery; Drug discovery / Combinatorial biology; Drug discovery / Combinatorial chemistry; Pharmaceutical / Nutrition; Pharmaceutical / Prescription; Pharmaceutical / OTC/Non-Prescription; Pharmaceutical / Generics; Pharmaceutical / Personal Care; Research tools / Biomarkers; Research tools / Antibodies; Research tools / Antigens; Research tools / Cell lines; Research tools / Mouse models; Service / Advertising; Service / Business services; Service / Consultancy; Service / Event management; Service / Market research; Service / Marketing; Service / Materials; Service / Public relations; Service / Regulatory affairs
Therapeutic target: Accident and Trauma; Accident and Trauma / Bone fractures; Accident and Trauma / Burns; Blood and forming organs; Cardiovascular / Anticoagulants; Cardiovascular / Blood clotting; Cardiovascular; Cardiovascular / Cardiovascular disorder (other); Cardiovascular / Thrombotic disorders; Cardiovascular / Cerebrovascular disorders; Cardiovascular / Cerebrovascular disorders / Aneurysm; Cardiovascular / Treatments / Cardioprotection; Cardiovascular / Acute coronary syndromes / Coronary artery disease; Cardiovascular / Acute coronary syndromes / Coronary heart disease; Cardiovascular / Cardiovascular disorder (other) / Diabetic cardiovascular disease; Cardiovascular / Blood composition / Dyslipidemia; Cardiovascular / Blood composition / Hypercholesterolemia; Cardiovascular / Blood composition / Hypertriglyceridemia; Cardiovascular / Acute coronary syndromes / Myocardial infarction; Cardiovascular / Vascular / Atherosclerosis; Cardiovascular / Acute coronary syndromes / Angina; Cardiovascular / Blood composition / Hyperlipidemia; Cardiovascular / Thrombotic disorders / Peripheral vascular disease; Central Nervous System; Central Nervous System / Psychiatric / Depression; Dermatological; Dermatological / Burns; Dermatological / Cosmetic procedures; Dermatological / Dermal ulcers; Dermatological / Dermatitis, allergic; Dermatological / Impetigo; Dermatological / Insect bite; Dermatological / Lupus; Dermatological / Acne; Dermatological / Fungal infection; Dermatological / Psoriasis; Dermatological / Skin infection (other); Dermatological / Eczema; Dermatological / Dermatological (other); Dermatological / Bacterial infection; Dermatological / Dermatitis, atopic; Dermatological / Wound healing; Endocrinology / Estrogen replacement; Endocrinology / Menopause; Endocrinology / Endocrine system; Gastrointestinal; Gastrointestinal / Gastritis; Gastrointestinal / Ulcer, gastric; Gastrointestinal / Ulcer, gastroduodenal; Gastrointestinal / Ulcer, peptic; Gastrointestinal / Irritable bowel syndrome; Gastrointestinal / Ulcer; Gastrointestinal / Inflammatory bowel disease; Gastrointestinal / Constipation; Genito-urinary; Genito-urinary / Urinary / Diabetic nephropathy; Genito-urinary / Urinary / Kidney disorder (other); Genito-urinary / Gender related medicine male / Male erectile dysfunction; Genito-urinary / Gender related medicine female / Menopause; Genito-urinary / Gender related medicine male / Prostatitis; Genito-urinary / Urinary / Renal disease; Genito-urinary / Urinary / Renal failure; Genito-urinary / Gender related medicine female / Women's health (other); Immune related disorders; Immune related disorders / Immunostimulation; Infectious diseases; Infectious diseases / Diseases / Infection, bacterial(other); Infectious diseases / Diseases / Cholera; Infectious diseases / Diseases / Infectious disease (other); Infectious diseases / Diseases / Influenza; Infectious diseases / Diseases / Streptococcal infections; Infectious diseases / Diseases / Infection, fungal (other); Infectious diseases / Diseases / Infection, viral (other); Infectious diseases / Treatments / Antibodies; Infectious diseases / Treatments / Vaccine; Metabolism; Metabolism / Diabetes type II; Metabolism / Diabetic complications; Metabolism / Obesity; Metabolism / Diabetes type I; Musculoskeletal; Musculoskeletal / Age-related disorders (other); Musculoskeletal / Hypomobility; Musculoskeletal / Skeletal / Bone fractures; Musculoskeletal / Skeletal / Bone repair/regeneration; Musculoskeletal / Skeletal / Osteopetrosis; Musculoskeletal / Skeletal / Osteoporosis; Oncology; Oncology / Anti-oxidant; Oncology / Breast cancer; Oncology / Liver cancer; Oncology / Prostate cancer; Oncology / Cancer side effects / Chemotherapy side effects; Oncology / Kidney cancer / Renal cell carcinoma; Oncology / Treatments / Vaccines; Other therapeutic / Chinese medicine; Respiratory; Respiratory / Asthma; Sensory organ; Sensory organ / Opthalmic / Diabetic retinopathy; Sensory organ / Opthalmic / Glaucoma; Sensory organ / Opthalmic / Macular degeneration; Sensory organ / Opthalmic / Retinopathy

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us